
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In situ PEGylation of CAR T cells alleviates cytokine release syndrome and neurotoxicity
Ningqiang Gong, Xuexiang Han, Lulu Xue, et al.
Nature Materials (2023) Vol. 22, Iss. 12, pp. 1571-1580
Closed Access | Times Cited: 33
Ningqiang Gong, Xuexiang Han, Lulu Xue, et al.
Nature Materials (2023) Vol. 22, Iss. 12, pp. 1571-1580
Closed Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
Jiaqi Shi, Wei Wu, Dong Chen, et al.
Nature Materials (2024) Vol. 23, Iss. 6, pp. 844-853
Closed Access | Times Cited: 22
Jiaqi Shi, Wei Wu, Dong Chen, et al.
Nature Materials (2024) Vol. 23, Iss. 6, pp. 844-853
Closed Access | Times Cited: 22
Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control
Li Lu, Mingqi Xie, Bo Yang, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 19
Li Lu, Mingqi Xie, Bo Yang, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 19
Novel strategies to manage CAR-T cell toxicity
Arthur Mulvey, Lionel Trueb, George Coukos, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Arthur Mulvey, Lionel Trueb, George Coukos, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Current and emerging pharmacotherapies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis-like syndrome due to CAR T cell therapy
Zandra E. Walton, Matthew J. Frigault, Marcela V. Maus
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 263-279
Closed Access | Times Cited: 9
Zandra E. Walton, Matthew J. Frigault, Marcela V. Maus
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 263-279
Closed Access | Times Cited: 9
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 8
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 8
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
Engineering cells for therapy and diagnosis
Zhaoting Li, Yixin Wang, Zhen Gu, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 9, pp. 770-784
Closed Access | Times Cited: 7
Zhaoting Li, Yixin Wang, Zhen Gu, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 9, pp. 770-784
Closed Access | Times Cited: 7
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
Ningqiang Gong, Wenqun Zhong, Mohamad‐Gabriel Alameh, et al.
Nature Materials (2024)
Closed Access | Times Cited: 7
Ningqiang Gong, Wenqun Zhong, Mohamad‐Gabriel Alameh, et al.
Nature Materials (2024)
Closed Access | Times Cited: 7
High-Throughput In Vivo Screening Identifies Differential Influences on mRNA Lipid Nanoparticle Immune Cell Delivery by Administration Route
Alex G. Hamilton, Kelsey L. Swingle, Ajay S. Thatte, et al.
ACS Nano (2024) Vol. 18, Iss. 25, pp. 16151-16165
Closed Access | Times Cited: 6
Alex G. Hamilton, Kelsey L. Swingle, Ajay S. Thatte, et al.
ACS Nano (2024) Vol. 18, Iss. 25, pp. 16151-16165
Closed Access | Times Cited: 6
Advancing cell surface modification in mammalian cells with synthetic molecules
Yang He, Lihua Yao, Yichen Wang, et al.
Chemical Science (2023) Vol. 14, Iss. 46, pp. 13325-13345
Open Access | Times Cited: 13
Yang He, Lihua Yao, Yichen Wang, et al.
Chemical Science (2023) Vol. 14, Iss. 46, pp. 13325-13345
Open Access | Times Cited: 13
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Wenzhe Yi, Songnian Hu, Xindi Qian, et al.
Exploration (2025)
Open Access
Wenzhe Yi, Songnian Hu, Xindi Qian, et al.
Exploration (2025)
Open Access
Delivering living medicines with biomaterials
Tetsuhiro Harimoto, Wei‐Hung Jung, David Mooney
Nature Reviews Materials (2025)
Closed Access
Tetsuhiro Harimoto, Wei‐Hung Jung, David Mooney
Nature Reviews Materials (2025)
Closed Access
Recent advances in biomaterial designs for assisting CAR-T cell therapy towards potential solid tumor treatment
Yu-Ting Lin, Ying Chen, Zheng Luo, et al.
Nanoscale (2024) Vol. 16, Iss. 7, pp. 3226-3242
Open Access | Times Cited: 4
Yu-Ting Lin, Ying Chen, Zheng Luo, et al.
Nanoscale (2024) Vol. 16, Iss. 7, pp. 3226-3242
Open Access | Times Cited: 4
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
Weihuan Shao, Yiran Yao, Ludi Yang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Weihuan Shao, Yiran Yao, Ludi Yang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Designable Nanoadaptor for Enhanced Recognition of Natural Killer Cell to Tumor via Bio-orthogonal Click Reaction
Xiaohu Yang, Hongchao Yang, Tuanwei Li, et al.
Nano Letters (2024) Vol. 24, Iss. 25, pp. 7698-7705
Closed Access | Times Cited: 4
Xiaohu Yang, Hongchao Yang, Tuanwei Li, et al.
Nano Letters (2024) Vol. 24, Iss. 25, pp. 7698-7705
Closed Access | Times Cited: 4
Engineering Cells for Cancer Therapy
Peixin Liu, Quanyin Hu
Accounts of Chemical Research (2024) Vol. 57, Iss. 16, pp. 2358-2371
Closed Access | Times Cited: 4
Peixin Liu, Quanyin Hu
Accounts of Chemical Research (2024) Vol. 57, Iss. 16, pp. 2358-2371
Closed Access | Times Cited: 4
DNA Origami Plasmonic Nanoantenna for Programmable Biosensing of Multiple Cytokines in Cancer Immunotherapy
Jie Tang, Ji Chen, Xing Lü, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 23, pp. 9684-9692
Closed Access | Times Cited: 3
Jie Tang, Ji Chen, Xing Lü, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 23, pp. 9684-9692
Closed Access | Times Cited: 3
Systemic Multifunctional Nanovaccines for Potent Personalized Immunotherapy of Acute Myeloid Leukemia
Peng Zhang, Tanzhen Wang, Guanhong Cui, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 3
Peng Zhang, Tanzhen Wang, Guanhong Cui, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 3
Synthesis of Antifouling Poly(ethylene glycol) Brushes via “Grafting to” Approach for Improved Biodistribution
Kaijie Zhao, Mengqi Li, Huimin Geng, et al.
Biomacromolecules (2024)
Closed Access | Times Cited: 3
Kaijie Zhao, Mengqi Li, Huimin Geng, et al.
Biomacromolecules (2024)
Closed Access | Times Cited: 3
Nanoengineered Macrophages Armed with TLR7/8 Agonist Enhance Remodeling of Immunosuppressive Tumor Microenvironment
Yeon Jeong Yoo, Ryounho Eun, Hye-Min Park, et al.
Small (2023) Vol. 20, Iss. 13
Open Access | Times Cited: 6
Yeon Jeong Yoo, Ryounho Eun, Hye-Min Park, et al.
Small (2023) Vol. 20, Iss. 13
Open Access | Times Cited: 6
Bioactive-material-programmed CAR-T cell living drug for augmented immunotherapy against tumors
Guojun Huang, Zhongliang Tang, Ting Yin, et al.
Cell Reports Physical Science (2024) Vol. 5, Iss. 6, pp. 102022-102022
Open Access | Times Cited: 1
Guojun Huang, Zhongliang Tang, Ting Yin, et al.
Cell Reports Physical Science (2024) Vol. 5, Iss. 6, pp. 102022-102022
Open Access | Times Cited: 1
Engineering strategies to mitigate toxicities associated with CAR‐T cell therapy
Tyler Wolter, Yixin Wang, Quanyin Hu
BMEMat (2024)
Open Access | Times Cited: 1
Tyler Wolter, Yixin Wang, Quanyin Hu
BMEMat (2024)
Open Access | Times Cited: 1
Nanoparticle-mediated universal CAR-T therapy
Mingliang Fan, Jiayu Zheng, Yue Huang, et al.
International Journal of Pharmaceutics (2024), pp. 124779-124779
Closed Access | Times Cited: 1
Mingliang Fan, Jiayu Zheng, Yue Huang, et al.
International Journal of Pharmaceutics (2024), pp. 124779-124779
Closed Access | Times Cited: 1
Nanotechnology‐Assisted CAR ‐T‐Cell Therapy for Tumor Treatment
Yixin Wang, Allie Barrett, Quanyin Hu
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 5
Closed Access | Times Cited: 1
Yixin Wang, Allie Barrett, Quanyin Hu
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 5
Closed Access | Times Cited: 1
Amphiphilic Lipid Conjugate-mediated surface engineering of Placenta-Derived mesenchymal stem cells for alleviating liver damage and fibrosis
Sungjun Kim, Dae Hyun Lee, Hee Won Park, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158313-158313
Closed Access | Times Cited: 1
Sungjun Kim, Dae Hyun Lee, Hee Won Park, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158313-158313
Closed Access | Times Cited: 1